Lilly beats Wall Street profit view, ups 2012 forecast

 (And this is good news?  Increased profits for drug companies mean increased illnesses in people's lives.  AW)

The Indianapolis drugmaker on Wednesday said it earned $924 million, or 83 cents per share, in the second quarter, compared with $1.2 billion, or $1.07 per share, a year earlier.
Excluding special items, the company earned 83 cents per share. Analysts on average expected 77 cents, according to Thomson Reuters I/B/E/S.

"The (earnings) beat was due to stronger underlying demand of key products such as Cymbalta, as well as the favorable impact of a stronger U.S. dollar on our cost of goods sold," said Lilly.



Lilly beats Wall Street profit view, ups 2012 forecast | Reuters